Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» InterMune
InterMune
Lax Approval Requirements Yield Blockbusters That Don’t Work
Xconomy
Fri, 03/13/20 - 11:54 pm
FDA
drug approvals
conditional approvals
InterMune
Actimmune
IPF
Pharma's top 10 M&A deals of 2014
Fierce Pharma
Thu, 02/19/15 - 07:51 am
M&A
Actavis
Allergan
Forest Labs
GSK
Novartis
Bayer
Merck
Cubist Pharma
Roche
InterMune
Mylan Labs
Abbott Labs
Questcor
Mallinckrodt
Eli Lilly
Sun Pharma
Ranbaxy
The Nominees for Best Biotechnology Co. CEO of 2014 Are...
TheStreet.com
Fri, 12/12/14 - 09:37 am
biotech
EXACT Sciences
Idenix
Prosensa
Agios Pharmaceuticals
Bluebird Bio
InterMune
Roche launches US$5.75bn bond to back InterMune deal -lead
Yahoo/Reuters
Mon, 09/22/14 - 03:43 pm
Roche
InterMune
M&A
InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action
Yahoo/PR Newswire
Sun, 09/21/14 - 10:38 am
InterMune
Roche CEO Schwan took a hands-on approach negotiating $8.3B InterMune buyout
Fierce Biotech
Wed, 09/3/14 - 10:12 pm
Roche
Pharma CEOs
Severin Schwan
M&A
InterMune
Roche, InterMune a Strategic Play in Midst of Inversions
TheStreet.com
Wed, 08/27/14 - 10:08 am
Roche
InterMune
tax inversions
M&A
There's still hunger for 'blockbuster' biotech deals
CNBC
Mon, 08/25/14 - 11:58 am
biotech
Roche
InterMune
M&A
Roche And InterMune Beckon Pharma's Summer of Discontent
Forbes
Mon, 08/25/14 - 09:59 am
Roche
InterMune
M&A
Roche Said to Have Decided Against Bid for Rest of Chugai
Bloomberg
Mon, 08/25/14 - 09:10 am
Roche
Chugai
M&A
InterMune
Roche CEO On Intermune Deal: 'This Is A Growth Story'
Forbes
Mon, 08/25/14 - 08:37 am
Pharma CEOs
InterMune
Roche
M&A
Severin Schwan
Roche to buy U.S. biotech firm InterMune for $8.3 billion
Yahoo/Reuters
Mon, 08/25/14 - 08:20 am
Roche
InterMune
M&A
Roche's InterMune Acquisition Underscores How It And Pfizer Are On Different M&A Paths
Forbes
Mon, 08/25/14 - 08:14 am
Roche
InterMune
Pfizer
M&A
Most Popular News Headlines For Wednesday, August 13 2014
CP Wire
Thu, 08/14/14 - 10:11 am
Pfizer
Bristol-Myers Squibb
Eliquis
Belsomra
insomnia
Kyprolis
Aranesp
Amgen
InterMune
Sanofi
Roche
Most popular news headlines for Wednesday, August 13 2014
Thu, 08/14/14 - 10:09 am
Pfizer
Bristol-Myers Squibb
Eliquis
Belsomra
insomnia
Kyprolis
Aranesp
Amgen
InterMune
Sanofi
Roche
InterMune buyout rumors resurface, with Roche, Sanofi on the short list
Fierce Biotech
Wed, 08/13/14 - 05:29 pm
InterMune
Roche
Sanofi
M&A
4 Biotech Stocks Worth A Look Ahead Of FDA Approvals
Yahoo/Benzinga
Thu, 07/3/14 - 12:07 pm
FDA
drug approvals
Acadia
Alexion
InterMune
Merrimack Pharmaceuticals
Soliris
pimavanserin
MM-398
Esbriet
The Path to FDA Approval Could Launch Seven Biotech Stocks Much Higher
24/7 Wall St
Wed, 07/2/14 - 11:49 am
Alexion
InterMune
FDA
Acadia
Kythera
Intercept Pharmaceuticals
Merrimack Pharmaceuticals
Relypsa
MM-398
patiromer
Esbriet
ATX-101
Soliris
Flint
pimavanserin
InterMune's A Strong Buy As Esbriet Finally Has The Data Physicians, Patients, And FDA Have Longed For
Seeking Alpha
Sun, 06/15/14 - 06:31 pm
InterMune
Esbriet
Actelion
Gilead Sciences
After Idenix: The Next Four Biotech Buyout Candidates
24/7 Wall St
Tue, 06/10/14 - 08:43 am
Idenix
M&A
Merck
Biocryst
Dynavax
InterMune
Vertex Pharmaceuticals
Pages
1
2
3
4
5
6
7
8
next ›
last »